Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, September 22, 2022
FDA Approves Aponvie (aprepitant) for the Prevention of Postoperative Nausea and Vomiting (PONV)
›
In continuation of my update on aprepitant Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving t...
Monday, September 12, 2022
Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA
›
About Rett Syndrome Rett syndrome is a rare genetic neurodevelopmental disorder that occurs primarily in females following a near normal dev...
Thursday, July 21, 2022
FDA Approves Amvuttra (vutrisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
›
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administrat...
Thursday, June 16, 2022
FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes
›
The U.S. Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-...
Tuesday, June 14, 2022
FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
›
Mitsubishi Tanabe Pharma Corporation (MTPA) announced the U.S. Food and Drug Administration (FDA) approval of Radicava ORS (edaravone), ...
Monday, June 13, 2022
Voquezna Triple Pak (amoxicillin, clarithromycin, and vonoprazan) FDA Approval
›
The Voquezna Triple and Dual Paks offer physicians the flexibility of two different treatment options. The Voquezna Triple Pak contains clar...
Saturday, June 11, 2022
FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy
›
In continuation of my update on mavacamten Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval...
Friday, June 10, 2022
FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults
›
Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, ...
Thursday, June 2, 2022
FDA Approves Tlando (testosterone undecanoate) for Male Hypogonadism
›
Antares Pharma, Inc., (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Admini...
‹
›
Home
View web version